Encompass Health (NYSE:EHC) Issues FY 2024 Earnings Guidance

Encompass Health (NYSE:EHC - Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 3.770-4.060 for the period, compared to the consensus EPS estimate of 3.970. The company issued revenue guidance of $5.2 billion-$5.3 billion, compared to the consensus revenue estimate of $5.3 billion.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Stephens reaffirmed an overweight rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Truist Financial increased their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a research report on Friday, February 9th. Mizuho increased their price objective on Encompass Health from $77.00 to $82.00 and gave the stock a buy rating in a research report on Friday, February 9th. Royal Bank of Canada restated an outperform rating and issued a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Finally, Barclays raised their price target on Encompass Health from $95.00 to $101.00 and gave the stock an overweight rating in a research report on Thursday. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Buy and an average price target of $83.22.

Encompass Health Price Performance

EHC traded up $4.89 during trading on Thursday, reaching $82.60. 1,859,934 shares of the company were exchanged, compared to its average volume of 633,871. The company's 50-day moving average is $74.34 and its two-hundred day moving average is $68.90. The company has a market cap of $8.27 billion, a price-to-earnings ratio of 23.80, a P/E/G ratio of 1.42 and a beta of 0.93. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. Encompass Health has a 12-month low of $52.56 and a 12-month high of $83.73.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.12. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. Research analysts forecast that Encompass Health will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health's dividend payout ratio (DPR) is presently 17.29%.

Institutional Investors Weigh In On Encompass Health

Several institutional investors have recently bought and sold shares of the stock. Worth Asset Management LLC purchased a new stake in Encompass Health in the 1st quarter worth approximately $35,000. Quarry LP purchased a new position in shares of Encompass Health in the 1st quarter valued at approximately $42,000. Belpointe Asset Management LLC lifted its stake in shares of Encompass Health by 88.2% in the 1st quarter. Belpointe Asset Management LLC now owns 781 shares of the company's stock valued at $42,000 after purchasing an additional 366 shares during the period. Benjamin Edwards Inc. lifted its stake in shares of Encompass Health by 89.0% in the 2nd quarter. Benjamin Edwards Inc. now owns 1,087 shares of the company's stock valued at $74,000 after purchasing an additional 512 shares during the period. Finally, First Horizon Advisors Inc. lifted its stake in shares of Encompass Health by 18.8% in the 1st quarter. First Horizon Advisors Inc. now owns 1,415 shares of the company's stock valued at $77,000 after purchasing an additional 224 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.